TY  - GEN
AU  - Hoeper,Marius M
AU  - Barst,Robyn J
AU  - Bourge,Robert C
AU  - Feldman,Jeremy
AU  - Frost,Adaani E
AU  - Galié,Nazzareno
AU  - Gómez-Sánchez,Miguel Angel
AU  - Grimminger,Friedrich
AU  - Grünig,Ekkehard
AU  - Hassoun,Paul M
AU  - Morrell,Nicholas W
AU  - Peacock,Andrew J
AU  - Satoh,Toru
AU  - Simonneau,Gérald
AU  - Tapson,Victor F
AU  - Torres,Fernando
AU  - Lawrence,David
AU  - Quinn,Deborah A
AU  - Ghofrani,Hossein-Ardeschir
TI  - Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study
SN  - 1524-4539
PY  - 2013///0503
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Benzamides
KW  - Double-Blind Method
KW  - Exercise Tolerance
KW  - drug effects
KW  - Familial Primary Pulmonary Hypertension
KW  - Female
KW  - Hematoma, Subdural
KW  - chemically induced
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - drug therapy
KW  - Imatinib Mesylate
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - administration & dosage
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCULATIONAHA.112.000765
ER  -